Skip to main content

Peer Review reports

From: Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study

Original Submission
23 Mar 2023 Submitted Original manuscript
31 Mar 2023 Reviewed Reviewer Report
4 Apr 2023 Reviewed Reviewer Report
4 May 2023 Author responded Author comments - Andreas Straube
Resubmission - Version 2
4 May 2023 Submitted Manuscript version 2
Publishing
7 May 2023 Editorially accepted
23 May 2023 Article published 10.1186/s10194-023-01593-2

You can find further information about peer review here.

Back to article page